首页> 美国卫生研究院文献>Molecular Metabolism >Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease
【2h】

Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease

机译:非酒精脂肪肝病中的核受体和转录调控

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

As a result of a sedentary lifestyle and excess food consumption in modern society, non-alcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver is becoming a major disease burden. Non-alcoholic steatohepatitis (NASH) is an advanced form of NAFLD characterized by inflammation and fibrosis that can lead to hepatocellular carcinoma and liver failure. Nuclear receptors (NRs) are a family of ligand-regulated transcription factors that closely control multiple aspects of metabolism. Their transcriptional activity is modulated by various ligands, including hormones and lipids. NRs serve as potential pharmacological targets for NAFLD/NASH and other metabolic diseases.
机译:由于久坐的生活方式和现代社会中的食物消耗过多,非酒精性脂肪肝病(NAFLD)以肝脏脂肪积累的特征为特征,正在成为一个主要的疾病负担。非酒精脂肪性肝炎(NASH)是一种先进的NAFLD,其特征是炎症和纤维化,可导致肝细胞癌和肝功能衰竭。核受体(NRS)是一种配体调节的转录因子系列,可密切控制代谢的多个方面。它们的转录活性由各种配体调节,包括激素和脂质。 NRS作为NAFLD / NASH和其他代谢疾病的潜在药理靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号